At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
tACS (alpha) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Clinical Trial for the Evaluation of Feedback Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder
In Brief
A clinical study evaluating tACS (alpha) and tACS (gamma) for Major Depressive Disorder and MDD. Completed, enrolled 32 participants across 1 site.
Detailed Summary
Investigating the effects of non-invasive transcranial alternating current stimulation (tACS) on patients with Major Depressive Disorder (MDD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder, MDD
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 2015
Enrollment StartMay 2015
Primary CompletionJun 2017
TodayJul 2026
First PostedJan 15, 2015
Enrollment StartMay 7, 2015
Primary CompletionJun 19, 2017
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 11.5 years ago
Interventions
tACS (alpha)device
tACS (gamma)device